Tennis superstar Novak Djokovic, who was deported from Australia for his unvaccinated status, reportedly holds a significant stake in a drug manufacturer developing Covid pills in Denmark.
Djokovic and his wife, Jelena, have invested in QuantBioRes A/S and are holding an 80% stake in the Copenhagen–based company, which is experimenting with treatments for COVID-19, Bloomberg reported, citing local newspaper BT.
QuantBioRes A/S chief executive director Ivan Loncarevic has confirmed Djokovic’s stake holdings in the company to the newspaper.
“Officially, it is Novak Djokovic and his wife Jelena who each have their share of the company, along with another couple,” Ivan Loncarevic said.
“I have worked with innovation for 20 years, I always deal with what I call real innovation. Fortunately, investors have believed in me in the past,” he said. “Not to brag about myself, but I have a nose for innovation.”
The drugmaker has not yet brought a Covid-19 treatment to the market.
But according to the company’s director, the treatment will undergo clinical studies in London over the summer.
Bloomberg citing BT’s website reported that QuantBioRes attempts to interfere with the virus by employing the resonant recognition model.
According to the newspaper BT, Djokovic owns a 40.8% stake in the drugmaker, his wife Jelena owns 39.2%, while Anthony Slingsby and his wife own the remaining 20%. The Djokovics bought their stakes in June 2020.
Djokovic missed the Australian Open this month after Australian authorities rejected his visa, claiming he had not got vaccinated and that they are protecting the country’s borders amid the COVID-19 pandemic.
Djokovic’s lawyers argued the tennis player did not need proof of vaccination because he had evidence that he recovered from the virus last month. However, a federal court in Australia upheld its government’s decision to revoke Djokovic’s visa.